Play Solana gaming handheld PSG1 to launch token PLAY, with 56% allocated to the community
Foresight News reported that Play Solana announced the issuance of the first-generation gaming handheld PSG1's token, PLAY, with 56% allocated to the community and 44% to others. Rewards can be earned by completing tasks and campaigns, purchasing Play Solana products (PSG1, merchandise, NFT), staking in games, as well as participating in social, consecutive, and community activities. Specifically, users holding Player1 and Player2 NFTs can receive daily XP rewards through a multiplier mechanism, and will also receive one-time extra rewards: Player1: 10,000 XP; Player2: 5,000 XP. These extra XP will be released before the token generation event (TGE), giving holders a first-mover advantage. Alongside player NFTs, the PSG1 gaming console is also considered one of the highest-level tasks, with each purchase granting at least 1,000 XP and future access to more benefits directly related to PLAY. In addition, its new badge system has extended this mechanism to the broader Solana community.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Janus Henderson Macro Head Says Market Is Near Its Top but Cannot Say When
A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.
Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.
Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request
A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.
After years of waiting and another delay, Tesla (TSLA.US) postpones the Roadster debut to October 15 as severe weather forces the event to stop.
Tesla has rescheduled the unveiling event for its next-generation Roadster, originally planned for this week, to October 15.
